To prevent muscle loss on GLP-1 injections, you must prioritize two things: adequate protein intake (aim for 0.8 to 1.0 grams of protein per pound of target body weight) and consistent, progressive resistance training
Cuprous glutathione: With a note on the crystallography of glutathione
Phase 3 Update: TRIUMPH-4 Results Preliminary data from the ongoing Phase 3 TRIUMPH-4 trial (68 weeks) shows higher numbers than Phase 2: 12mg dose: 28.7% average weight loss (~71 lbs / 32 kg) 9mg dose: 26.4% average weight loss (~64 lbs / 29 kg) Knee osteoarthritis pain: 76% reduction (significant quality-of-life improvement) Blood pressure: Average reduction of 14 mmHg Full Phase 3 results across the TRIUMPH program (obesity, diabetes, cardiovascular outcomes, kidney outcomes) are expected throughout 2026
According to analysts, GLP-1s could dramatically affect food consumption, negatively impacting fast food and snack companies
The goal is to determine whether GLP-1 treatment is safe, appropriate, and likely to help you achieve and maintain a healthier, sustainable weight